How a premier U.S. drug company became a virus ‘super spreader'

New York Times

12 April 2020 - Biogen employees unwittingly spread the coronavirus from Massachusetts to Indiana, Tennessee and North Carolina.

On the first Monday in March, Michel Vounatsos, chief executive of the drug company Biogen, appeared in good spirits. The company’s new Alzheimer’s drug was showing promise after years of setbacks. Revenues had never been higher.

Onstage at an elite health care conference in Boston, Mr. Vounatsos touted the drug’s “remarkable journey.” Asked if the coronavirus that was ravaging China would disrupt supply chains and upend the company’s big plans, Mr. Vounatsos said no.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Public health , COVID-19